Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $20.1 million.

  • Voyager Therapeutics' Long-Term Investments rose 59871.26% to $20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year increase of 59871.26%. This contributed to the annual value of $65.7 million for FY2024, which is 402454.49% up from last year.
  • Voyager Therapeutics' Long-Term Investments amounted to $20.1 million in Q3 2025, which was up 59871.26% from $46.4 million recorded in Q2 2025.
  • Over the past 5 years, Voyager Therapeutics' Long-Term Investments peaked at $65.7 million during Q4 2024, and registered a low of $1.5 million during Q2 2022.
  • For the 5-year period, Voyager Therapeutics' Long-Term Investments averaged around $11.6 million, with its median value being $1.8 million (2021).
  • Per our database at Business Quant, Voyager Therapeutics' Long-Term Investments crashed by 3257.68% in 2022 and then skyrocketed by 402454.49% in 2024.
  • Quarter analysis of 5 years shows Voyager Therapeutics' Long-Term Investments stood at $1.8 million in 2021, then dropped by 14.84% to $1.5 million in 2022, then rose by 5.15% to $1.6 million in 2023, then surged by 4024.54% to $65.7 million in 2024, then crashed by 69.44% to $20.1 million in 2025.
  • Its Long-Term Investments stands at $20.1 million for Q3 2025, versus $46.4 million for Q2 2025 and $59.1 million for Q1 2025.